Related Experiment Videos
c-FMS mutational analysis in acute myeloid leukaemia
British Journal of Haematology
|November 18, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis.
Journal of cardiovascular development and disease·2021
Molecular Evaluation of HIF-1α Gene Variation and Determination of Its Frequency and Association with Breast Cancer Susceptibility in Saudi Arabia.
Endocrine, metabolic & immune disorders drug targets·2020
Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service.
International journal of neonatal screening·2019
Phosphatidylinositol 3-kinase Glu545Lys and His1047Tyr Mutations are not Associated with T2D.
Current diabetes reviews·2019
Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders.
Neuroscience and biobehavioral reviews·2019
Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.
British journal of haematology·2026
CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.
British journal of haematology·2026
The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.
British journal of haematology·2026
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026